Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 11, Issue 12, pp. 2704-2708
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 28, 2012
- Revision received August 26, 2012
- Accepted August 31, 2012
- Published first September 7, 2012.
Article Versions
- Previous version (September 7, 2012 - 12:57).
- Previous version (November 30, 2012 - 12:43).
- You are viewing the most recent version of this article.
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- James S. Wilmott1,2,
- Varsha Tembe1,2,3,4,
- Julie R. Howle1,2,5,
- Raghwa Sharma5,
- John F. Thompson1,2,6,
- Helen Rizos1,2,3,4,
- Roger S. Lo7,8,9,
- Richard F. Kefford1,2,3,4,5,
- Richard A. Scolyer1,2,6, and
- Georgina V. Long1,2,3,4,5
- Authors' Affiliations: 1Melanoma Institute Australia; 2The University of Sydney; 3Westmead Institute for Cancer Research; 4Westmead Millennium Institute; 5Westmead Hospital; 6Royal Prince Alfred Hospital; Sydney, New South Wales, Australia; 7Divisions of Dermatology/Department of Medicine; 8Jonsson Comprehensive Cancer Center; and 9Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California
- Corresponding Author:
Georgina V. Long, Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Road, North Sydney 2060, New South Wales, Australia. Phone: 61-2-9911-7200; Fax: 61-2-9954-9435; E-mail: georgina.long{at}sydney.edu.au
J. S. Wilmott and V. Tembe contributed equally to this work.
December 2012
Volume 11, Issue 12
Volume 11, Issue 12
Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine
Jump to section
Advertisement